Literature DB >> 15273747

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

Paul Gregorevic1, Michael J Blankinship, James M Allen, Robert W Crawford, Leonard Meuse, Daniel G Miller, David W Russell, Jeffrey S Chamberlain.   

Abstract

A major obstacle limiting gene therapy for diseases of the heart and skeletal muscles is an inability to deliver genes systemically to muscles of an adult organism. Systemic gene transfer to striated muscles is hampered by the vascular endothelium, which represents a barrier to distribution of vectors via the circulation. Here we show the first evidence of widespread transduction of both cardiac and skeletal muscles in an adult mammal, after a single intravenous administration of recombinant adeno-associated virus pseudotype 6 vectors. The inclusion of vascular endothelium growth factor/vascular permeability factor, to achieve acute permeabilization of the peripheral microvasculature, enhanced tissue transduction at lower vector doses. This technique enabled widespread muscle-specific expression of a functional micro-dystrophin in the skeletal muscles of dystrophin-deficient mdx mice, which model Duchenne muscular dystrophy. We propose that these methods may be applicable for systemic delivery of a wide variety of genes to the striated muscles of adult mammals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273747      PMCID: PMC1365046          DOI: 10.1038/nm1085

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  33 in total

1.  Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation.

Authors:  Charles R Bridges; James M Burkman; Ramin Malekan; Stephane M Konig; Haiyan Chen; Charles B Yarnall; Timothy J Gardner; Alan S Stewart; Mark M Stecker; Terry Patterson; Hansell H Stedman
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

2.  Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.

Authors:  C L Halbert; E A Rutledge; J M Allen; D W Russell; A D Miller
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.

Authors:  C L Halbert; J M Allen; A D Miller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Immune evasion by muscle-specific gene expression in dystrophic muscle.

Authors:  D Hartigan-O'Connor; C J Kirk; R Crawford; J J Mulé; J S Chamberlain
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

5.  Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.

Authors:  M A Hauser; A Robinson; D Hartigan-O'Connor; D A Williams-Gregory; J N Buskin; S Apone; C J Kirk; S Hardy; S D Hauschka; J S Chamberlain
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

6.  Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.

Authors:  W K Cho; S Ebihara; J Nalbantoglu; R Gilbert; B Massie; P Holland; G Karpati; B J Petrof
Journal:  Hum Gene Ther       Date:  2000-03-20       Impact factor: 5.695

7.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle.

Authors:  A Musarò; K McCullagh; A Paul; L Houghton; G Dobrowolny; M Molinaro; E R Barton; H L Sweeney; N Rosenthal
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

8.  Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.

Authors:  A Ahmad; M Brinson; B L Hodges; J S Chamberlain; A Amalfitano
Journal:  Hum Mol Genet       Date:  2000-10-12       Impact factor: 6.150

9.  Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery.

Authors:  Masahiko Hoshijima; Yasuhiro Ikeda; Yoshitaka Iwanaga; Susumu Minamisawa; Moto-o Date; Yusu Gu; Mitsuo Iwatate; Manxiang Li; Lili Wang; James M Wilson; Yibin Wang; John Ross; Kenneth R Chien
Journal:  Nat Med       Date:  2002-07-22       Impact factor: 53.440

10.  A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.

Authors:  Stephen M Eppler; Daniel L Combs; Timothy D Henry; John J Lopez; Stephen G Ellis; Joo-Hee Yi; Brian H Annex; Edward R McCluskey; Thomas F Zioncheck
Journal:  Clin Pharmacol Ther       Date:  2002-07       Impact factor: 6.875

View more
  259 in total

Review 1.  Cardiac gene therapy: from concept to reality.

Authors:  Razmig Garo Kratlian; Roger J Hajjar
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 2.  Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.

Authors:  Kristen J Nowak; Kay E Davies
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

3.  Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino.

Authors:  Bo Wu; Peijuan Lu; Caryn Cloer; Mona Shaban; Snimar Grewal; Stephanie Milazi; Sapana N Shah; Hong M Moulton; Qi Long Lu
Journal:  Am J Pathol       Date:  2012-06-07       Impact factor: 4.307

4.  Whole body skeletal muscle transduction in neonatal dogs with AAV-9.

Authors:  Yongping Yue; Jin-Hong Shin; Dongsheng Duan
Journal:  Methods Mol Biol       Date:  2011

Review 5.  The evolution of heart gene delivery vectors.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Dongsheng Duan
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

6.  Truncated dystrophins can influence neuromuscular synapse structure.

Authors:  Glen B Banks; Jeffrey S Chamberlain; Stanley C Froehner
Journal:  Mol Cell Neurosci       Date:  2009-01-08       Impact factor: 4.314

7.  AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.

Authors:  Stephen C Kolwicz; Guy L Odom; Sarah G Nowakowski; Farid Moussavi-Harami; Xiaolan Chen; Hans Reinecke; Stephen D Hauschka; Charles E Murry; Gregory G Mahairas; Michael Regnier
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

8.  Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.

Authors:  Lennart Suckau; Henry Fechner; Elie Chemaly; Stefanie Krohn; Lahouaria Hadri; Jens Kockskämper; Dirk Westermann; Egbert Bisping; Hung Ly; Xiaomin Wang; Yoshiaki Kawase; Jiqiu Chen; Lifan Liang; Isaac Sipo; Roland Vetter; Stefan Weger; Jens Kurreck; Volker Erdmann; Carsten Tschope; Burkert Pieske; Djamel Lebeche; Heinz-Peter Schultheiss; Roger J Hajjar; Wolfgang C Poller
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

9.  Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.

Authors:  Chunping Qiao; Jianbin Li; Tong Zhu; Romesh Draviam; Simon Watkins; Xiaojing Ye; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

10.  AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart.

Authors:  Xiufang Pan; Yongping Yue; Keqing Zhang; Chady H Hakim; Kasun Kodippili; Thomas McDonald; Dongsheng Duan
Journal:  Hum Gene Ther Methods       Date:  2015-04-01       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.